SCI's Q2 Looks Better-But Does the New $105 UBS Target Pass the Smell Test?

Q2 improved the picture, but one quarter still does not settle the story

SCI's second quarter looked noticeably better than the rougher first quarter. The company reported $0.90 EPS on about $1.10 billion in revenue, with revenue up 3.6% year over year. The same source says it beat expectations, while the wider market data confirms the company's Buy rating and Strong Buy consensus.

Why the timing matters

Just after the quarter, UBS lifted its target to $105 from $93, and the broader consensus moved to $100.33. That is the core of the setup: the market is giving SCI a better look because fresh results arrived, but it has not yet granted full credit for the full-year recovery.

The bull case is straightforward. If SCI can keep modest sales growth and steady execution going, today's optimism may still be conservative. The bear case is just as clear: one solid quarter does not prove a lasting turnaround. The key question is whether Q2 was a true turning point or simply breathing room after a weak start.

The stronger part of the business is cemetery, not funeral

Q2 improved the headline, but the mix matters more. In the last available segment read-through, funeral segment revenue declined by 2.9% while cemetery segment revenue grew by 6.9%. That split is more informative than the overall tape because it shows which side of the business has the sturdier demand base.

Pre-need gives cemetery a more predictable core

Cemetery looks like the cleaner part of the model. Cemetery demand benefits from pre-need sales and property revenue, which means some demand is booked before families need services in an emergency. That can make cash flows steadier and give the business more pricing resilience than a model that depends mostly on immediate, walk-in demand.

Management also said it saw strong preneed cemetery and funeral sales, which supports the idea that the recent improvement was not just a one-off quarter. At minimum, it suggests pre-need activity and advance planning are still contributing.

Scale and brands help SCI stay relevant locally

SCI is not just an abstract financial story. It operates over 1,493 funeral service locations and 496 cemeteries, including combination sites. That footprint gives families local access to providers they may already know or have been referred to.

That local presence matters because funeral and cemetery choices are often made quickly and emotionally. A recognized brand such as Dignity Memorial can help reduce uncertainty for families, which can support both retention and pricing.

The 2025 backdrop still shows modest but healthy growth

SCI's 2025 results also point to a business that is still growing, even if not explosively. In 2025, revenue was $4.31 billion, an increase of 2.93%, and earnings were $542.61 million, an increase of 4.62%. That is the kind of backdrop investors want to see when they are deciding whether a defensive operator is stabilizing.

What has to happen next for the stock case to hold

The recent quarter changed the story enough to pay attention, but not enough to get comfortable too early.

The next proof point is follow-through

The next major trigger is another quarter of steady execution. The latest evidence was $0.90 EPS on about $1.10 billion in revenue, with revenue up 3.6% year over year. The latest analyst action added momentum: UBS raised its target to $105, and the broader consensus sits at $100.33.

Over the next two to three months, investors should watch two things: whether pre-need activity is translating into sustained sales flow, and whether cash-flow confidence improves after a weaker first quarter that included adjusted EPS of $0.97.

What would strengthen or weaken the case

A stronger case would show steady revenue growth, continued cemetery strength, and no deterioration in the pre-need trend. A weaker case would show the funeral segment still dragging, cemetery momentum cooling, or the market deciding Q2 was only temporary relief. In other words, this is now a verification trade, not a blind faith trade.